ASCO GI 2021 | Real-world outcomes of patients with intrahepatic CCA treated with trans-arterial radioembolization

Thomas Helmberger, MD, PhD, Muenchen Klinik Bogenhausen, München, Germany, presents the results of a multi-center observational study designed to evaluate the clinical outcomes of patients with intrahepatic cholangiocarcinoma (CCA) treated with trans-arterial radioembolization (TARE) in the real-life clinical setting. The results from this large prospective multi-center observational study show that in the real-world context, TARE is applied early and successfully in the treatment pathway. TARE is shown to be an effective and safe treatment with no meaningful deterioration of quality of life. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).